GHW International
9933.HK
Hong Kong Stock Exchange1.50
HKD
- -
- -
GHW International
9933.HK
(Hong Kong Stock Exchange)
Recent
price
1.50
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- GHW International is a global high-tech manufacturing enterprise headquartered in Nanjing, China, specializing in the research, development, production, and sales of applied chemicals, pharmaceutical intermediates, bio-based products, as well as sports and health products. Founded in 1995, the company operates through multiple business segments including Methylamine Industry Series, Applied Chemicals Series, Advanced Materials Intermediates Series, Green Products, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (APIs), Iodine Derivatives and Supporting Products, and the Happy Elephant Planet Advanced Medical and Health Products segment. Its product portfolio encompasses animal nutrition chemical products such as choline chloride and betaine; polyurethane materials including polymer polyether and modified methylene diphenyl diisocyanate; fine chemical products; cardanol-based green products; pharmaceutical intermediates like cefpodoxime proxetil dispersible tablets; iodine derivatives; and a range of nutrition and health products sourced from third parties. The company serves customers across the People’s Republic of China, Southeast Asia, Europe, North America, and other international markets. In recent strategic developments, GHW International has expanded its footprint in health technology by entering into an exclusive distribution agreement with SWISSCOAT Vision (China) Limited to promote and sell customized medical optical lenses under the brand “瑞士寶” in China. The company continues to advance its strategy focused on green development, digital transformation, and globalization. It maintains comprehensive R&D capabilities, multiple production bases domestically and overseas, and an extensive warehousing and logistics system supporting over 40,000 clients worldwide. GHW also collaborates with governmental health authorities, exemplified by recent talks with Vietnam’s Ministry of Health to jointly explore pharmaceutical sector cooperation. GHW International’s operations span chemicals and pharmaceuticals industries, targeting markets in animal nutrition, construction, automotive, home appliances, coatings, and pharmaceuticals. The company maintains a global presence with subsidiaries in more than ten countries, supported by a supply chain of over 600 raw material suppliers. GHW emphasizes sustainable development, product quality, safety, and environmental protection as core principles underpinning its global manufacturing and sales activities. This comprehensive scope and recent strategic initiatives position GHW International as a diversified and integrated provider of chemical intermediates and advanced medical products with continued growth focus in health technology and international market expansion.